This site uses cookies, tags and tracking settings to store information that help give you the very best browsing experience. If you don't change your settings, we'll assume you're happy with this. More information Dismiss this warning

SYT7 plays a role in promoting thyroid cancer by mediating HMGB3 ubiquitination

in Endocrine-Related Cancer
Authors:
Shuai Dong The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Search for other papers by Shuai Dong in
Current site
Google Scholar
PubMed Close
,
Jun Pan The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Search for other papers by Jun Pan in
Current site
Google Scholar
PubMed Close
,
Yi-Bin Shen The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Search for other papers by Yi-Bin Shen in
Current site
Google Scholar
PubMed Close
,
Li-Xian Zhu The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Search for other papers by Li-Xian Zhu in
Current site
Google Scholar
PubMed Close
,
Liang Chen The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Search for other papers by Liang Chen in
Current site
Google Scholar
PubMed Close
,
Feng Zhu The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Search for other papers by Feng Zhu in
Current site
Google Scholar
PubMed Close
,
Hui Li Zhejiang University, Hangzhou, Zhejiang, China

Search for other papers by Hui Li in
Current site
Google Scholar
PubMed Close
,
Hai-Xiang Shen Zhejiang University, Hangzhou, Zhejiang, China

Search for other papers by Hai-Xiang Shen in
Current site
Google Scholar
PubMed Close
,
Qing Xia People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, China

Search for other papers by Qing Xia in
Current site
Google Scholar
PubMed Close
,
Yi-Jun Wu The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Search for other papers by Yi-Jun Wu in
Current site
Google Scholar
PubMed Close
, and
Xiao-Jun Xie The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Search for other papers by Xiao-Jun Xie in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0002-4173-1067

Correspondence should be addressed to Q Xia or Y-J Wu or X-J Xie: xiaqing_zj@163.com or wuwu5925@zju.edu.cn or xxj701023@zju.edu.cn

*(S Dong and J Pan contributed equally to this work)

DOI:
https://doi.org/10.1530/ERC-21-0146
Volume/Issue:
Volume 29: Issue 4
Article Type:
Research Article
Page Range:
175–189
Online Publication Date:
01 Mar 2022
Copyright:
© Society for Endocrinology 2022
Restricted access
Rent on DeepDyve

Sign up for journal news

Thyroid cancer is one of the most common endocrine malignancies. It is necessary to discover more effective molecular targets for the treatment of thyroid cancer. The results of immunohistochemical staining, qPCR and Western blot indicated that the expression of SYT7 in thyroid cancer tissues and cells was higher than that in paracarcinoma tissues and normal thyroid cells. Through cell function testing experiments, it was found that SYT7 knockdown inhibited the proliferation and migration of thyroid cancer cells and promoted cell apoptosis, while SYT7 overexpression had the opposite effect. Similarly, SYT7 downregulation also suppressed tumor growth in vivo. HMGB3 was confirmed to be the downstream gene of SYT7 by GeneChip and Ingenuity Pathway Analysis. Besides, through UbiBrowser database predictions and Co-IP assays, we found that SYT7 interacted with BRCA1 to inhibit HMGB3 ubiquitination and thus upregulated the protein level of HMGB3. Similar to SYT7, HMGB3 was significantly upregulated in thyroid cancer. HMGB3 knockdown inhibited the proliferation and migration of thyroid cancer cells and promoted cell apoptosis. Furthermore, HMGB3 knockdown restored the promotion of cell proliferation and migration caused by SYT7 overexpression. SYT7 and HMGB3 were upregulated in thyroid cancer, and SYT7 regulated the expression of HMGB3 through BRCA1-mediated ubiquitination of HMGB3 to promote thyroid cancer progression.

Supplementary Materials

Endocrine-Related Cancer is committed to supporting researchers in demonstrating the impact of their articles published in the journal.

The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.

More information is on the Reasons to publish page.

 

  • Collapse
  • Expand
Print ISSN:
1351-0088
Online ISSN:
1479-6821
Accepted Manuscripts
Volume: 32 (2025)
Show Items
Volume: 31 (2024)
Show Items
Volume: 30 (2023)
Show Items
Volume: 29 (2022)
Show Items
Volume: 28 (2021)
Show Items
Volume: 27 (2020)
Show Items
Volume: 26 (2019)
Show Items
Volume: 25 (2018)
Show Items
Volume: 24 (2017)
Show Items
Volume: 23 (2016)
Show Items
Volume: 22 (2015)
Show Items
Volume: 21 (2014)
Show Items
Volume: 20 (2013)
Show Items
Volume: 19 (2012)
Show Items
Volume: 18 (2011)
Show Items
Volume: 17 (2010)
Show Items
Volume: 16 (2009)
Show Items
Volume: 15 (2008)
Show Items
Volume: 14 (2007)
Show Items
Volume: 13 (2006)
Show Items
Volume: 12 (2005)
Show Items
Volume: 11 (2004)
Show Items
Volume: 10 (2003)
Show Items
Volume: 9 (2002)
Show Items
Volume: 8 (2001)
Show Items
Volume: 7 (2000)
Show Items
Volume: 6 (1999)
Show Items
Volume: 5 (1998)
Show Items
Volume: 4 (1997)
Show Items
Volume: 3 (1996)
Show Items
Volume: 2 (1995)
Show Items
Volume: 1 (1994)
Show Items
Copyright:
© Society for Endocrinology 2022
Page(s):
15
Received Date:
22 Nov 2021
Accepted Date:
24 Jan 2022
Print Publication Date:
01 Apr 2022
Online Publication Date:
01 Mar 2022
Keywords:
thyroid cancer; SYT7; HMGB3; proliferation; migration; apoptosis

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA & Jemal A 2018 Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 68 394–424. (https://doi.org/10.3322/caac.21492)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Cabanillas ME, Ryder M & Jimenez C 2019 Targeted therapy for advanced thyroid cancer: kinase inhibitors and beyond. Endocrine Reviews 40 1573–1604. (https://doi.org/10.1210/er.2019-00007)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Chmielik E, Rusinek D, Oczko-Wojciechowska M, Jarzab M, Krajewska J, Czarniecka A & Jarzab B 2018 Heterogeneity of thyroid cancer. Pathobiology 85 117–129. (https://doi.org/10.1159/000486422)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Colvin RA, Means TK, Diefenbach TJ, Moita LF, Friday RP, Sever S, Campanella GS, Abrazinski T, Manice LA & Moita C et al.2010 Synaptotagmin-mediated vesicle fusion regulates cell migration. Nature Immunology 11 495–502. (https://doi.org/10.1038/ni.1878)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Donoghue LJ, Livraghi-Butrico A, McFadden KM, Thomas JM, Chen G, Grubb BR, O’Neal WK, Boucher RC & Kelada SNP 2017 Identification of trans protein QTL for secreted airway mucins in mice and a causal role for Bpifb1. Genetics 207 801–812. (https://doi.org/10.1534/genetics.117.300211)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, Caillou B, Ricard M, Lumbroso JD & De Vathaire F et al.2006 Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. Journal of Clinical Endocrinology and Metabolism 91 2892–2899. (https://doi.org/10.1210/jc.2005-2838)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Fang J, Ge X, Xu W, Xie J, Qin Z, Shi L, Yin W, Bian M & Wang H 2020 Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer. Journal of Cellular Physiology 235 3438–3446. (https://doi.org/10.1002/jcp.29233)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Fei Z, Gao W, Xie R, Feng G, Chen X & Jiang Y 2019 Synaptotagmin-7, a binding protein of P53, inhibits the senescence and promotes the tumorigenicity of lung cancer cells. Bioscience Reports 39 BSR20181298. (https://doi.org/10.1042/BSR20181298)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G & Woodbrook R et al.2015 The Global Burden of Cancer 2013. JAMA Oncology 1 505–527. (https://doi.org/10.1001/jamaoncol.2015.0735)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Gallego LD, Schneider M, Mittal C, Romanauska A, Gudino Carrillo RM, Schubert T, Pugh BF & Kohler A 2020 Phase separation directs ubiquitination of gene-body nucleosomes. Nature 579 592–597. (https://doi.org/10.1038/s41586-020-2097-z)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Geppert M, Goda Y, Hammer RE, Li C, Rosahl TW, Stevens CF & Sudhof TC 1994 Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse. Cell 79 717–727. (https://doi.org/10.1016/0092-8674(9490556-8)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Gustavsson N, Lao Y, Maximov A, Chuang JC, Kostromina E, Repa JJ, Li C, Radda GK, Sudhof TC & Han W 2008 Impaired insulin secretion and glucose intolerance in synaptotagmin-7 null mutant mice. PNAS 105 3992–3997. (https://doi.org/10.1073/pnas.0711700105)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Huang C, Walker EM, Dadi PK, Hu R, Xu Y, Zhang W, Sanavia T, Mun J, Liu J & Nair GG et al.2018 Synaptotagmin 4 regulates pancreatic beta cell maturation by modulating the Ca(2+) sensitivity of insulin secretion vesicles. Developmental Cell 45 347.e5–361.e5. (https://doi.org/10.1016/j.devcel.2018.03.013)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Jackman SL, Turecek J, Belinsky JE & Regehr WG 2016 The calcium sensor synaptotagmin 7 is required for synaptic facilitation. Nature 529 88–91. (https://doi.org/10.1038/nature16507)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Ji J, Ding K, Luo T, Zhang X, Chen A, Zhang D, Li G, Thorsen F, Huang B & Li X et al.2021 TRIM22 activates NF-kappaB signaling in glioblastoma by accelerating the degradation of IkappaBalpha. Cell Death and Differentiation 28 367–381. (https://doi.org/10.1038/s41418-020-00606-w)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Kim J, Gosnell JE & Roman SA 2020 Geographic influences in the global rise of thyroid cancer. Nature Reviews: Endocrinology 16 17–29. (https://doi.org/10.1038/s41574-019-0263-x)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Li Y, Luo K, Yin Y, Wu C, Deng M, Li L, Chen Y, Nowsheen S, Lou Z & Yuan J 2017 USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response. Nature Communications 8 15752. (https://doi.org/10.1038/ncomms15752)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Liu X, Li C, Yang Y, Liu X, Li R, Zhang M, Yin Y & Qu Y 2019 Synaptotagmin 7 in twist-related protein 1-mediated epithelial–mesenchymal transition of non-small cell lung cancer. eBiomedicine 46 42–53. (https://doi.org/10.1016/j.ebiom.2019.07.071)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Liu D, Wang Y, Zhao Y & Gu X 2020 LncRNA SNHG5 promotes nasopharyngeal carcinoma progression by regulating miR-1179/HMGB3 axis. BMC Cancer 20 178. (https://doi.org/10.1186/s12885-020-6662-5)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Naoum GE, Morkos M, Kim B & Arafat W 2018 Novel targeted therapies and immunotherapy for advanced thyroid cancers. Molecular Cancer 17 51. (https://doi.org/10.1186/s12943-018-0786-0)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Nemeth MJ, Curtis DJ, Kirby MR, Garrett-Beal LJ, Seidel NE, Cline AP & Bodine DM 2003 Hmgb3: an HMG-box family member expressed in primitive hematopoietic cells that inhibits myeloid and B-cell differentiation. Blood 102 1298–1306. (https://doi.org/10.1182/blood-2002-11-3541)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Nemeth MJ, Cline AP, Anderson SM, Garrett-Beal LJ & Bodine DM 2005 Hmgb3 deficiency deregulates proliferation and differentiation of common lymphoid and myeloid progenitors. Blood 105 627–634. (https://doi.org/10.1182/blood-2004-07-2551)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Park JW, Kang JY, Hahm JY, Kim HJ & Seo SB 2020 Proteosomal degradation of NSD2 by BRCA1 promotes leukemia cell differentiation. Communications Biology 3 462. (https://doi.org/10.1038/s42003-020-01186-8)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Petit A, Ragu C, Della-Valle V, Mozziconacci MJ, Lafage-Pochitaloff M, Soler G, Schluth C, Radford I, Ottolenghi C & Bernard OA et al.2010 NUP98-HMGB3: a novel oncogenic fusion. Leukemia 24 654–658. (https://doi.org/10.1038/leu.2009.241)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Rizo J & Sudhof TC 1998 C2-domains, structure and function of a universal Ca2+-binding domain. Journal of Biological Chemistry 273 15879–15882. (https://doi.org/10.1074/jbc.273.26.15879)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Roth EM, Lubitz CC, Swan JS & James BC 2020 Patient-reported quality-of-life outcome measures in the thyroid cancer population. Thyroid 30 1414–1431. (https://doi.org/10.1089/thy.2020.0038)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Segovia M, Ales E, Montes MA, Bonifas I, Jemal I, Lindau M, Maximov A, Sudhof TC & Alvarez de Toledo G 2010 Push-and-pull regulation of the fusion pore by synaptotagmin-7. PNAS 107 19032–19037. (https://doi.org/10.1073/pnas.1014070107)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Starita LM, Machida Y, Sankaran S, Elias JE, Griffin K, Schlegel BP, Gygi SP & Parvin JD 2004 BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number. Molecular and Cellular Biology 24 8457–8466. (https://doi.org/10.1128/MCB.24.19.8457-8466.2004)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Sugita S, Han W, Butz S, Liu X, Fernandez-Chacon R, Lao Y & Sudhof TC 2001 Synaptotagmin VII as a plasma membrane Ca(2+) sensor in exocytosis. Neuron 30 459–473. (https://doi.org/10.1016/s0896-6273(0100290-2)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Tang Z, Zhang J, Zhou Q, Xu S, Cai Z & Jiang G 2020 Thyroid cancer ‘epidemic’: a socio-environmental health problem needs collaborative efforts. Environmental Science and Technology 54 3725–3727. (https://doi.org/10.1021/acs.est.0c00852)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Vaccari T, Beltrame M, Ferrari S & Bianchi ME 1998 Hmg4, a new member of the Hmg1/2 gene family. Genomics 49 247–252. (https://doi.org/10.1006/geno.1998.5214)

  • van Wijk SJ, Fulda S, Dikic I & Heilemann M 2019 Visualizing ubiquitination in mammalian cells. EMBO Reports 20 2. (https://doi.org/10.15252/embr.201846520)

  • Veiga LH, Neta G, Aschebrook-Kilfoy B, Ron E & Devesa SS 2013 Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997–2008. Thyroid 23 748–757. (https://doi.org/10.1089/thy.2012.0532)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Viola D, Valerio L, Molinaro E, Agate L, Bottici V, Biagini A, Lorusso L, Cappagli V, Pieruzzi L & Giani C et al.2016 Treatment of advanced thyroid cancer with targeted therapies: ten years of experience. Endocrine-Related Cancer 23 R185–R205. (https://doi.org/10.1530/ERC-15-0555)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Virmani T, Han W, Liu X, Sudhof TC & Kavalali ET 2003 Synaptotagmin 7 splice variants differentially regulate synaptic vesicle recycling. EMBO Journal 22 5347–5357. (https://doi.org/10.1093/emboj/cdg514)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Wang K, Xiao H, Zhang J & Zhu D 2018 Synaptotagmin7 is overexpressed in colorectal cancer and regulates colorectal cancer cell proliferation. Journal of Cancer 9 2349–2356. (https://doi.org/10.7150/jca.25098)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Wang H, Zhou Y, Oyang L, Han Y, Xia L, Lin J, Tang Y, Su M, Tan S & Tian Y et al.2019a LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-kappaB activity in nasopharyngeal carcinoma. Oncogene 38 5062–5075. (https://doi.org/10.1038/s41388-019-0778-6)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Wang J, Sheng Z & Cai Y 2019b Effects of microRNA-513b on cell proliferation, apoptosis, invasion, and migration by targeting HMGB3 through regulation of mTOR signaling pathway in non-small-cell lung cancer. Journal of Cellular Physiology 234 10934–10941. (https://doi.org/10.1002/jcp.27921)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Wu Z, Sun Z, Huang R, Zang D, Wang C, Yan X & Yan W 2020 Silencing of synaptotagmin 7 regulates osteosarcoma cell proliferation, apoptosis, and migration. Histology and Histopathology 35 303–312. (https://doi.org/10.14670/HH-18-174)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Xiao B, Li J, Fan Y, Ye M, Lv S, Xu B, Chai Y, Zhou Z, Wu M & Zhu X 2017 Downregulation of SYT7 inhibits glioblastoma growth by promoting cellular apoptosis. Molecular Medicine Reports 16 9017–9022. (https://doi.org/10.3892/mmr.2017.7723)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Xie X, Pan J, Han X & Chen W 2019 Downregulation of microRNA-532-5p promotes the proliferation and invasion of bladder cancer cells through promotion of HMGB3/Wnt/beta-catenin signaling. Chemico-Biological Interactions 300 73–81. (https://doi.org/10.1016/j.cbi.2019.01.015)

    • PubMed
    • Search Google Scholar
    • Export Citation